Description

Corinfar (nifedipine) retard tablets with prolonged release 20 mg. №30 blister

Ingredients

Active ingredient: Nifedipine 20 mg.
Other ingredients: lactose monohydrate, cellulose microcrystalline, colloidal anhydrous silica, magnesium stearate.

Dosage

Adults: The usual dose is one tablet every 12 hours. The dosage may vary depending on the individual’s condition and response to treatment. Consult a healthcare professional for personalized recommendations.

Indications

Corinfar (nifedipine) retard tablets are indicated for the treatment of hypertension (high blood pressure) and angina pectoris (chest pain).

Contraindications

Do not use Corinfar (nifedipine) retard tablets if:

• You are allergic to nifedipine or any other ingredients in the product.
• You have severe hypotension (low blood pressure).
• You are pregnant or breastfeeding without medical advice.

Directions

Swallow the tablets whole with a glass of water. Do not crush or chew the tablets. Take the medication as prescribed by your healthcare provider. Follow all instructions carefully.

Scientific Evidence

Nifedipine, the active ingredient in Corinfar retard tablets, is a calcium channel blocker that works by relaxing and widening blood vessels. This action helps to lower blood pressure and improve blood flow to the heart, reducing the workload on the heart muscle. Several studies have demonstrated the efficacy of nifedipine in the management of hypertension and angina.

Additional Information

It is important to adhere to the prescribed dosage and follow-up appointments with your healthcare provider while taking Corinfar (nifedipine) retard tablets. Inform your doctor about any other medications or supplements you are taking to avoid potential drug interactions. In case of any adverse effects or concerns, seek medical assistance promptly.

Research studies have shown that nifedipine not only effectively lowers blood pressure but also reduces the frequency of angina episodes in patients with coronary artery disease. The prolonged-release formulation of Corinfar provides a steady release of the medication, ensuring consistent blood levels and prolonged therapeutic effects.

Clinical trials comparing nifedipine with other antihypertensive agents have demonstrated its comparable efficacy and safety profile. The convenience of a once-daily dosing regimen with Corinfar (nifedipine) retard tablets offers improved compliance and better management of hypertension and angina.